These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The advantage of polymer addition to a non-ionic oil in water microemulsion for the dermal delivery of progesterone. Biruss B; Valenta C Int J Pharm; 2008 Feb; 349(1-2):269-73. PubMed ID: 17869457 [TBL] [Abstract][Full Text] [Related]
26. Comparative study of progesterone plasma levels after nasal spray and intramuscular administration of natural progesterone in menopausal women. Cicinelli E; Savino F; Cagnazzo I; Scorcia P Gynecol Obstet Invest; 1993; 35(3):172-4. PubMed ID: 8505011 [TBL] [Abstract][Full Text] [Related]
27. Topical progesterone cream has an antiproliferative effect on estrogen-stimulated endometrium. Leonetti HB; Wilson KJ; Anasti JN Fertil Steril; 2003 Jan; 79(1):221-2. PubMed ID: 12524095 [No Abstract] [Full Text] [Related]
28. Use of Pro-Gest cream in postmenopausal women. Stevenson JC; Purdie DW Lancet; 1998 Sep; 352(9131):905-6; author reply 906. PubMed ID: 9743011 [No Abstract] [Full Text] [Related]
29. [Resorption of progesterone through the intact skin of the breast in comparison with other body regions]. Krause W; Wichmann U; Horn W Geburtshilfe Frauenheilkd; 1987 Aug; 47(8):562-4. PubMed ID: 3653670 [TBL] [Abstract][Full Text] [Related]
30. Use of Pro-Gest cream in postmenopausal women. MacFarland SA Lancet; 1998 Sep; 352(9131):905; author reply 906. PubMed ID: 9743009 [No Abstract] [Full Text] [Related]
31. Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone. Archer DF; Fahy GE; Viniegra-Sibal A; Anderson FD; Snipes W; Foldesy RG Am J Obstet Gynecol; 1995 Aug; 173(2):471-7; discussion 477-8. PubMed ID: 7645623 [TBL] [Abstract][Full Text] [Related]
32. Enhancement of transdermal delivery of progesterone using medium-chain mono and diglycerides as skin penetration enhancers. Lopes LB; Murphy N; Nornoo A Pharm Dev Technol; 2009; 14(5):524-9. PubMed ID: 19552564 [TBL] [Abstract][Full Text] [Related]
33. Permeation Efficacy of a Transdermal Vehicle with Steroidal Hormones and Nonsteroidal Anti-inflammatory Agents as Model Drugs. Junqueira LA; Polonini H; Loures S; Raposo NRB; Ferreira AO; Brandão MAF Curr Drug Deliv; 2019; 16(2):136-141. PubMed ID: 30360741 [TBL] [Abstract][Full Text] [Related]
34. Deep tissue penetration of bases and steroids after dermal application in rat. Singh P; Roberts MS J Pharm Pharmacol; 1994 Dec; 46(12):956-64. PubMed ID: 7714719 [TBL] [Abstract][Full Text] [Related]
35. Progesterone creams: do they work? Wren BG Climacteric; 2003 Sep; 6(3):184-7. PubMed ID: 14567766 [No Abstract] [Full Text] [Related]
36. Influence of route of administration on progesterone metabolism. de Lignieres B; Dennerstein L; Backstrom T Maturitas; 1995 Apr; 21(3):251-7. PubMed ID: 7616875 [TBL] [Abstract][Full Text] [Related]
37. Oral administration of micronized progesterone: a review and more experience. McAuley JW; Kroboth FJ; Kroboth PD Pharmacotherapy; 1996; 16(3):453-7. PubMed ID: 8726605 [TBL] [Abstract][Full Text] [Related]
38. Drug absorption through mucosal membranes: effect of mucosal route and penetrant hydrophilicity. Corbo DC; Liu JC; Chien YW Pharm Res; 1989 Oct; 6(10):848-52. PubMed ID: 2608627 [TBL] [Abstract][Full Text] [Related]
39. Comparison of oral bioavailability of two dosage-forms of progesterone in women. Duclos R; Clabaut M; Daoust M Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():191-3. PubMed ID: 1820877 [TBL] [Abstract][Full Text] [Related]
40. Absorption of micronized progesterone from a nonliquefying vaginal cream. Kimzey LM; Gumowski J; Merriam GR; Grimes GJ; Nelson LM Fertil Steril; 1991 Nov; 56(5):995-6. PubMed ID: 1936339 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]